Table 1.

Associations of the expressions of Sox9, Wnt1, Fzd1 and Ki-67 with tumor clinical stages

	IIa stage (n = 22)	IIb/III stage (n = 26)	P-value
Sox9 expression
High (n, %)	9 (40.9)	23 (88.5)	P < 0.001*
Low (n, %)	13 (59.1)	3 (11.5)
Wnt1 expression
High (n, %)	11 (50.0)	24 (92.3)	P = 0.001*
Low (n, %)	11 (50.0)	2 (7.7)
Fzd1 expression
High (n, %)	6 (27.2)	21 (80.8)	P < 0.001*
Low (n, %)	16 (72.8)	5 (19.2)
Ki-67 expression
High (n, %)	7 (31.8)	19 (73.1)	P = 0.004*
Low (n, %)	15 (68.2)	7 (26.9)

^*With significant difference.